7487 Results

People

  1. Brennan
    Brennan
  2. Danishefsky
    Danishefsky
  3. Larson
    Larson
  4. Scheinberg
    Scheinberg
  5. Fuks
    Fuks
  6. Rosen
    Rosen
  7. Hricak
    Hricak
  8. Pasternak
    Pasternak
  9. Sadelain
    Sadelain
  10. Scardino
    Scardino

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)
  7. Radiology, Department of (1814)
  8. Hematologic Malignancies Research (1617)
  9. Hematologic Malignancies, Division of (1517)
  10. Center for Molecular Imaging and Biotechnology (1341)
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ultrasmall radioiodinated αMSH-C dots for melanoma imaging and therapy
    Meeting Abstract

    Zhang, X. L.; Benezra, M.; Ma, K.; Gallazzi, F.; Zhang, L.; Pauliah, M.; Wiesner, U.; Quinn, T. P.; Bradbury, M.
    Journal of Labelled Compounds and Radiopharmaceuticals (2015)

    Fulltext@MSK | Save
  • Allosteric Hsp70-family inhibitors as targeted anticancer therapeutics
    Meeting Abstract

    Koren, J.; Xu, C.; Rodina, A.; Shrestha, L.; Taldone, T.; Chiosis, G.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Development of selective Grp94 inhibitors for the treatment of cancer
    Meeting Abstract

    Ochiana, S. O.; Taldone, T.; Patel, H. J.; Patel, P.; Yan, P.; Sun, W. L.; Rodina, A.; Shah, S.; Gewirth, D. T.; Chiosis, G.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Development of chemical tools to study the endogenous Hsp70 interactome in malignant cells
    Meeting Abstract

    Rodina, A. A.; Taldone, T.; Kang, Y. L.; Patel, P.; Koren, J.; Yan, P.; DaGama Gomes, E.; Yang, C.; Patel, M.; Shrestha, L.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Human tumorigenesis induced by endogenous DNA transposase
    Meeting Abstract

    Henssen, A.; Eisenberg, A.; Jiang, E.; Henaff, E.; Koche, R.; Burns, M.; Carson, J. R.; Nanjangud, G.; Still, E.; Gandara, J.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Role of PRKD2 in HSP90-and hypoxia-mediated epithelial-to-mesenchymal transition
    Meeting Abstract

    Azoitei, N.; Becher, A.; Diepold, K.; Bobrovich, S.; Brunner, C.; Chiosis, G.; Fröhling, S.; Johan, V.; Scholl, C.; Seufferlein, T.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A hyperactive signalosome results in high sensitivity to HSP90 inhibitors in AML
    Meeting Abstract

    Zong, H. L.; Taldone, T.; Roboz, G. J.; Chiosis, G.; Guzman, M. L.
    Blood (2015)

    Fulltext@MSK | Save
  • PRMT1-mediated methylation of DUSP4 determines megakaryocyte-erythroid lineage choice by regulating p38 signaling
    Meeting Abstract

    Su, H. R.; Tran, N. T.; Guo, H.; Luo, M.; Zhao, X. T.
    Blood (2015)

    Fulltext@MSK | Save
  • High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse risk features and poor outcome in pediatric acute myeloid leukemia: A report from the Children's Oncology Group
    Meeting Abstract

    Laszlo, G. S.; Alonzo, T. A.; Gudgeon, C. J.; Harrington, K. H.; Kentsis, A.; Gerbing, R. B.; Wang, Y. C.; Ries, R. E.; Raimondi, S. C.; Hirsch, B. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Phase 1 trial of targeted alpha-particle immunotherapy with actinium-225 ((225)Ac)-lintuzumab (Anti-CD33) and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Levy, M. Y.; Estey, E. H.; Perl, A. E.; Kantarjian, H.; Earle, D.; more...
    Blood (2015)

    Fulltext@MSK | Save